Companies /Healthcare

Dyne Therapeutics Inc

NASDAQ: DYN Biotechnology
$24.28
▼ $0.67 (−2.69%) today
Markets closed · 9:09pm ET

DYN Coverage

Page 3
6:20am ET
Media

Media Digest (11/8/2011) Reuters, WSJ, NYT, FT, Bloomberg

Olympus says it concealed losses for decades. (Reuters) Italy’s sovereign debt interest rates rise sharply. (Reuters) Toyota’s (NYSE: TM) profits fall and it withdraws its full-year forecast. (Reuters) Greece cannot decide on…

Douglas A. McIntyre
9:38am ET
Investing

Dynegy Board: A Conflict Of Interest

Electric energy provider Dynegy (NYSE: DYN) has been through a great deal recently. It threatened to file Chapter 11. The firm said it might not be able to refinance a credit facility.…

DYN
Douglas A. McIntyre
9:55am ET
Investing

The 24/7 Wall St./Flame Index: March 10 GM CFO Goes

BP (NYSE: BP) stayed at the top of the list of companies receiving the most negative news after skepticism about its CEO’s apology about Deepwater Horizon. Dynegy (NYSE: DYN) threatened a Chapter…

Douglas A. McIntyre
9:37am ET
Investing

Icahn Bargain-Hunting for Dynegy (DYN, IEP, BX, NRG)

When Dynegy Inc. (NYSE: DYN) reported earnings, or rather, losses, yesterday, the company also included the dreaded “going concern” statement telling investors that unless the company could restructure its debt, Chapter 11…

Jon C. Ogg
8:52am ET
Investing

Dynegy Struggling to Remain a Going Concern (DYN, IEP)

After failing to pull the trigger on two buyout offers, Dynegy Corp. (NYSE: DYN) stated in its 10-K filing yesterday that it still has plenty of problems: “Our accompanying consolidated financial statements…

Jon C. Ogg